Double-Donor transplant trial aims to speed recovery for blood cancer patients
NCT ID NCT01810588
Summary
This study is testing a new transplant method for adults with serious blood cancers who need a stem cell transplant but lack a perfectly matched donor. Patients receive stem cells from two sources: umbilical cord blood and a partially matched family member. The goal is to see if focusing on better genetic matching, rather than just the number of cord cells, leads to faster recovery and better long-term survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
-
Weill Cornell Medical College
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.